Cell-Easy vs Omniabio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cell-easy/omniabio

Category	Cell-Easy	Omniabio
Listed site	cdmo	cdmo
Summary	Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.	OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
Services	Cell Therapy Manufacturing Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing	Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell Therapy Manufacturing Lentiviral Vector Manufacturing CMC Regulatory Submission Support
Modalities	Cell Therapy	Cell Therapy Gene Therapy
Indications	Oncology Immunology	Data not yet provided.
Locations	Headquarters, Toulouse, Occitanie, France	Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.